The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and

Y Gao1, S Tang, S Zhou

  • 1Department of Medicine, Cardiovascular Division, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10461, USA.

Insights

Thromboxane A2 receptor activation triggers extracellular regulated kinase (ERK) signaling through a G protein pathway. This involves protein kinase C, Src kinase, and epidermal growth factor receptor transactivation.

Area of Science:

  • Cellular signaling pathways
  • G protein-coupled receptors
  • Signal transduction

Background:

  • Mitogen-activated protein kinase (MAPK) cascades are crucial for cellular responses.
  • G protein-coupled receptors (GPCRs) initiate diverse functional events via signaling cascades.
  • The thromboxane A2 (TxA2) receptor (TP) is a GPCR implicated in various physiological processes.

Purpose of the Study:

  • To elucidate the signaling mechanisms by which the TxA2 receptor (TP) activates the MAPK cascade.
  • To investigate the roles of G proteins, Src kinase, epidermal growth factor receptor (EGFR), and protein kinase C (PKC) in TP-mediated signaling.

Main Methods:

  • Activation of ECV304 cells with IBOP (TxA2 mimetic).
  • Inhibition studies using specific antagonists and inhibitors (SQ29548, AG1478, PP1, pertussis toxin, calphostin C).
  • Assessment of extracellular regulated kinase (ERK) and EGFR phosphorylation, Src kinase activity, and G protein involvement via immunoprecipitation.

Main Results:

  • TP activation induced ERK and EGFR phosphorylation, dependent on Gi/o proteins, Src kinase, and PKC.
  • Src kinase activation preceded EGFR phosphorylation and was upstream of MAPK activation.
  • TP signaling to ERK required Gi protein coupling, mediated by PKC, leading to Src-dependent EGFR transactivation.

Conclusions:

  • The TP receptor is directly coupled to Gi proteins via a PKC-regulated mechanism.
  • Gi protein coupling initiates a Src-dependent transactivation of the EGFR.
  • This EGFR transactivation represents the dominant pathway for TP-mediated ERK activation.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
What are Second Messengers?02:04

What are Second Messengers?

Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...